O21 Is SLE-DAS better than BILAG-2004 to identify severe SLE disease activity? Post-hoc analysis of 438 SLE patients from the anifrolumab clinical trialsAndrea Doria,Diogo Jesus, Ana Matos,Carla Henriques,Luís Sousa InêsLupus Science and Medicine（2024）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
